Viewing StudyNCT00100815



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00100815
Status: COMPLETED
Last Update Posted: 2015-12-24
First Post: 2005-01-06

Brief Title: Gemcitabine Capecitabine and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
Sponsor: Roswell Park Cancer Institute
Organization: Roswell Park Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
stage IV pancreatic cancer View
adenocarcinoma of the pancreas View
recurrent pancreatic cancer View